Windlab (ASX:WND) Building A Business: HY 2018 Results

As a developer, operator and owner of wind farms, Windlab Ltd (ASX:WND) is at the forefront of the transition towards renewable energy. So how does Windlab stack up as an investment?

read more

Kip McGrath Education Centres (ASX:KME) FY 2018 Annual Results

The tutoring company Kip McGrath (ASX: KME) released its results on Friday showing a continuing implementation of its long term strategy. It’s steady as she goes.

read more

Catapult International (ASX:CAT) FY 2018 Results

Athlete performance monitoring company Catapult International (ASX:CAT) today released its annual report for FY 2018 -- with little for shareholders to smile about.

read more

Energy Action (ASX:EAX) Improving: FY 2018 Annual Results

Author: Mark Susanto

read more

Pro Medicus (ASX:PME) Keeps Growing: FY 2018 Annual Results

Radiology imaging company Pro Medicus (ASX:PME) released its results for the 2018 financial year this morning. These results provide further evidence that this truly is a hidden gem of a company.

read more

Nanosonics (ASX:NAN) Share Price Popping On Short Squeeze

A major reason to study short-sellers is that a weak short thesis can create opportunities to buy underpriced equity.

read more

Have I fallen in love with Capilano Honey Limited? (ASX:CZZ)

read more

Introduction to iCar Asia (ASX:ICQ)

read more

Speculative stocks

read more

1300 Smiles (ASX:ONT) Stays Steady: FY 2018 Annual Results

Dental aggregator 1300 Smiles announced a decent set of results today. Here are the highlights:

• Over-the-counter revenue up 9.6% to $55.8 million (this includes revenue earned by the self employed dentists that 1300 Smiles provides services to).


• Statutory revenue up 8.8% to $39.3 million


• Dividends up 4.3% to 24 cents or a trailing twelve month yield of 3.6% based on the current share price.


• Earnings-per-share (EPS) up 5% to 32.2 cents


• Net profit after tax (NPAT) up 5% to $7.6 million


• Free cash flow was $0.2 million compared to $3.6 million last year as the company ramped up its acquisition activity.


• Operating cash flow was up 18.2% to $10.4 million


• Net cash of $0.3 million

The following chart shows the relatively steady upward trajectory of the company over recent years barring the blip in 2013/2014 which was impacted by the withdrawal of the Chronic Disease Dental Scheme (CDDS). Note there is also a clear seasonality to the business with H1 typically stronger than H2. (Click image to view).

read more